96 related articles for article (PubMed ID: 23675671)
1. Ondansetron for diarrhea associated with neuroendocrine tumors.
Kiesewetter B; Raderer M
N Engl J Med; 2013 May; 368(20):1947-8. PubMed ID: 23675671
[No Abstract] [Full Text] [Related]
2. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs.
Kiesewetter B; Duan H; Lamm W; Haug A; Riss P; Selberherr A; Scheuba C; Raderer M
Oncologist; 2019 Feb; 24(2):255-258. PubMed ID: 30171068
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron and irritable bowel syndrome.
Luthra P; Ford AC
Gut; 2015 Jul; 64(7):1181. PubMed ID: 24846912
[No Abstract] [Full Text] [Related]
4. The fall and rise of 5-hydroxytryptamine receptor antagonists in irritable bowel syndrome with diarrhea.
Luthra P; Ford AC
Gastroenterology; 2014 Aug; 147(2):527-8. PubMed ID: 24953627
[No Abstract] [Full Text] [Related]
5. Effects of a 5-HT(3) antagonist, ondansetron, on fasting and postprandial small bowel water content assessed by magnetic resonance imaging.
Marciani L; Wright J; Foley S; Hoad CL; Totman JJ; Bush D; Hartley C; Armstrong A; Manby P; Blackshaw E; Perkins AC; Gowland PA; Spiller RC
Aliment Pharmacol Ther; 2010 Sep; 32(5):655-63. PubMed ID: 20626735
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors.
Janson ET
J Endocrinol Invest; 2005; 28(11 Suppl International):137-40. PubMed ID: 16625863
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Serotonin Synthesis May Have Antitumor Activity? Long-Term Efficacy in a Patient with Gastrointestinal Neuroendocrine Tumor.
Molina-Cerrillo J; Grande E; Alonso-Gordoa T
Oncologist; 2019 Jul; 24(7):e597-e599. PubMed ID: 30877189
[TBL] [Abstract][Full Text] [Related]
8. An antiemetic for irritable bowel syndrome?
Levy R; Corbo J; Prasad S
J Fam Pract; 2014 Oct; 63(10):600-2. PubMed ID: 25343149
[TBL] [Abstract][Full Text] [Related]
9. Revival of 5-HT3 antagonism as treatment of IBS-D?
Barbara G
Gut; 2014 Oct; 63(10):1530-2. PubMed ID: 24465028
[No Abstract] [Full Text] [Related]
10. 5HT3 receptor antagonists and pruritus due to cholestasis.
Quigley C
Palliat Med; 1996 Jan; 10(1):54. PubMed ID: 8821191
[No Abstract] [Full Text] [Related]
11. Diarrhea with ileal and hepatic abnormalities in a 52-year-old man.
Am J Med; 1998 Apr; 104(4):398-403. PubMed ID: 9576416
[No Abstract] [Full Text] [Related]
12. Is it time to widen the use of somatostatin analogs in neuroendocrine tumors?
Oberg KE
J Clin Oncol; 2009 Oct; 27(28):4635-6. PubMed ID: 19704053
[No Abstract] [Full Text] [Related]
13. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea.
von der Ohe MR; Camilleri M; Kvols LK
Gastroenterology; 1994 May; 106(5):1184-9. PubMed ID: 8174881
[TBL] [Abstract][Full Text] [Related]
14. [Intermittent facial flushing and diarrhea].
Füeβl HS
MMW Fortschr Med; 2015 Apr; 157(7):37. PubMed ID: 26060867
[No Abstract] [Full Text] [Related]
15. [Diagnostic and therapeutic management of diarrhea in human immunodeficiency virus infected patients].
Benhamou Y; Beaugerie L
Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B136-44. PubMed ID: 8522094
[No Abstract] [Full Text] [Related]
16. [5HT3 antagonists: ondansetron].
López de Ocariz A; Alvarez Medina P; Honorato J
Rev Med Univ Navarra; 1993; 38(1):43-9. PubMed ID: 8711309
[No Abstract] [Full Text] [Related]
17. Treatment of cholestatic itching in primary biliary cirrhosis with ondansetron.
Di Martino M; Galanti B; Nardiello S
Ital J Gastroenterol; 1995; 27(8):455. PubMed ID: 8775475
[No Abstract] [Full Text] [Related]
18. [Ondansetron for cholestatic pruritus].
Lamelo Alfonsín F; Vila Arias M; San Martín Moreira J; Silva César M
An Med Interna; 1998 Aug; 15(8):456. PubMed ID: 9780438
[No Abstract] [Full Text] [Related]
19. FDA approves marketing of octreotide.
Clin Pharm; 1989 Jan; 8(1):4. PubMed ID: 2912662
[No Abstract] [Full Text] [Related]
20. Inadvertent epidural injection of ondansetron.
Huang JJ
J Clin Anesth; 2006 May; 18(3):216-7. PubMed ID: 16731325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
